Drug class
Smooth-muscle spasmolytic; calcium-channel and phosphodiesterase inhibitor properties
Mechanism of action
Relaxes smooth muscle through calcium-channel blocking and phosphodiesterase-inhibitory effects. Proposed additional effects on glutamatergic signalling have been described, but the clinical mechanism is not fully established.
General use cases
- Used in some countries for symptomatic relief of visceral smooth-muscle spasm and selected otological or vestibular complaints; indications and evidence vary by jurisdiction and product
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
